
For years, healthcare providers across Europe have walked a tightrope when managing the life cycle of medical devices. On one hand, there is constant pressure to reduce costs and limit plastic waste. On the other hand, patient safety remains an absolute priority that can never be compromised.
Reprocessing single-use medical devices (SUDs)—the practice of cleaning, sterilizing, and testing a device originally designed for a single use so it can be safely used again—has emerged as a major sustainability strategy. Professional reprocessing can cut device procurement costs by up to half while keeping significant volumes of medical waste out of landfills.
But where should the line be drawn? At what point does cleaning a “disposable” device introduce unacceptable biological, technical, or clinical risk?
Portugal has officially answered that question. On May 5, 2026, the Portuguese Ministry of Health published Ministerial Order No. 206/2026/1 (Portaria n.º 206/2026/1) in the Diário da República. Effective from May 6, 2026, this decree establishes a definitive “no-reuse” list of single-use medical devices that are strictly prohibited from being reprocessed or reused in Portuguese territory.
For hospitals, clinics, third-party reprocessors, and device manufacturers operating in Portugal, this is more than an administrative update. It is a major regulatory milestone that directly affects clinical workflows, waste management strategies, and compliance obligations.
The Legal Backbone: MDR and National Enforcement
To understand why this list matters, you have to look at the broader legislative framework behind it. Ministerial Order No. 206/2026/1did not emerge in isolation, it is the national implementation of a wider European regulatory structure:
[EU Medical Devices Regulation (EU) 2017/745 (MDR)]
│
▼
[Portugal’s Decree-Law No. 29/2024]
│
▼
[Ministerial Order No. 206/2026/1 (May 2026)]
At the European level, Regulation (EU) 2017/745 (MDR) establishes strict rules for the medical technology sector. Under Article 17 of the MDR, EU Member States are allowed to authorize the reprocessing of single-use devices, but they also reserve the right to ban or restrict the practice on their own soil.
Portugal exercised this authority through Decree-Law No. 29/2024, which aligned national law with the MDR and empowered the Ministry of Health to define which devices may or may not be reprocessed.This mandate was further reinforced by amendments in Decree-Law No. 118/2025, which explicitly shifted responsibility for maintaining the prohibited list to a ministerial order, allowing for faster updates as technology and evidence.
By issuing Ministerial Order No. 206/2026/1, signed by the State Secretary of Health Ana Margarida Pinheiro Povo, Portugal has finalized this regulatory framework. The order aligns with the EU’s common specifications laid down in Commission Implementing Regulation (EU) 2020/1207, ensuring that any reprocessing activities meet the highest standards of safety, quality management, and traceability.
The ”No-Reuse” List: What Cannot Be Reprocessed?
The annex to the new Ministerial Order lists 14 specific categories of single-use medical devices that must be discarded immediately after use. No exceptions and no alternative pathways are permitted.
The prohibited categories largely reflect three core risk areas: residual contamination, material degradation, and mechanical or electronic failure.
Here is the breakdown of the prohibited devices:
1. High-Contamination and Infection Risks
- Devices for invasive procedures involving the central nervous system, eyes, or pituitary gland
- Devices associated with transmissible spongiform encephalopathies (e.g. Creutzfeldt-Jakob disease)
- Devices used on patients with undiagnosed neurological conditions meeting defined clinical criteria
2. Materials-Based and Chemical Risks
- Radiation-emitting devices and associated administration equipment
- Devices used to administer cytostatics or radiopharmaceuticals
- Drug-incorporated devices containing active medicinal substances
- Aesthetic and Annex XVI products (such as cosmetic contact lenses, dermal fillers, or liposuction equipment)
3. Mechanical and Electronic Risks
- Implantable Devices
- Devices with non-replaceable internal batteries
- Devices containing internal data storage essential for operation
- Cutting, drilling, or scraping devices subject to irreversible mechanical wear
4. Custom and Previously Reprocessed Devices
- Custom-Made Devices
- In-House Manufactured Devices under Article 5(5) of the MDR.
- Devices that have already undergone reprocessing once.
The Logistical Challenge: Managing Hospital Budgets and Waste
While the new law provides regulatoryclarity for clinical safety, it introduces immediate operational challenges for healthcare administrators across Portugal.
The Reprocessing Trade-off
| PROS of Reprocessing | CONS of Reprocessing |
| Up to 50% cost savings Drastic waste reduction Circular economy wins | Infection control risks Complex tracking system Rigid legal liabilities |
Historically, reprocessing has helped Portuguese hospitals control costs and meet sustainability targets. High-value single-use devices—such as electrophysiology catheters or ultrasonic scalpels—could often be safely reused within validated limits, generating substantial savings.
With this new list in place, several consequences are unavoidable:
- Budget Reallocation: Purchasing departments must brace for an increase in capital expenditure to buy new, single-use replacements for devices that can no longer be reprocessed.
- Higher volumes of hazardous medical waste:Discarding these devices immediately will lead to an uptick in Class III and Class IV medical waste (hazardous and infectious clinical waste). Hospitals will need to negotiate higher-volume waste management contracts, offsetting some of their sustainability initiatives.
- Rigid Inventory Tracking: To avoid severe compliance penalties, hospitals must implement software-based inventory tracking. Every single device entering a sterilization unit must be cross-referenced against the 14 prohibited categories to prevent accidental reprocessing.
Legal Liability: Who Carries the Risk?
Under Portugal’s Decree-Law No. 29: Any entity that reprocesses an allowed single-use device assumesall the liabilities of the original manufacturer. If a reprocessed device fails during a procedure, the liability no longer rests with the company that originally designed it. Instead, the reprocessing entity is fully responsible for any patient harm, product malfunction, or clinical failure.
By publishing this strict blacklist, the Portuguese government has significantly reduced the liability exposure for hospitals, simply by removing the highest-risk devices from the equation. However, for the devices that can still be reprocessed, robust quality management systems aligned with ISO 13485 and MDR requirements remain essential..
A Living List: Built for Scientific Evolution
One of the most practical aspects of Ministerial Order No. 206/2026/1 is that it is not intended to freeze innovation.. The text explicitly acknowledges that medical technology, clinical research, and material sciences evolve rapidly.
To prevent the law from stifling future innovation, the decree includes a built-in review mechanism. If a third-party reprocessor or a medical device manufacturer can scientifically prove that a previously banned category can be cleaned, sterilized, and tested with absolute, verifiable safety, the prohibited list can be updated. This keeps the legislation dynamic, ensuring that patient safety is protected without permanently locking out advanced technological solutions.
What This Means for Clinical and Administrative Teams
The publication of this order marks the end of regulatory ambiguity in Portugal. For stakeholders across the healthcare sector, the practical steps forward are clear:

- For Hospitals and Healthcare Centers: Internal clinical, sterilization, and waste management protocols must be updated immediately. Staff must be trained to ensure that banned items are routed directly to medical waste disposal rather than the central sterile services department (CSSD).
- For Outsourced Reprocessing Partners: Third-party companies providing reprocessing services to Portuguese healthcare networks must audit their inventories immediately. They must ensure they are not accepting, processing, or returning any devices on the prohibited list.
- For Supply Chain Managers: Procurement teams will need to adjust their budgets and purchasing forecasts to account for the loss of reprocessed inventory in high-volume clinical areas.
By setting these clear boundaries, Portugal is protecting patients while giving the healthcare industry a transparent, legally solid framework in which to safely pursue sustainability.
Compliance Beyond Borders — Partnering with TS Quality & Engineering
At TS Quality & Engineering, we understand that regulations like Portugal’s new “No‑Reuse” list are reshaping how hospitals, reprocessors, and manufacturers manage medical devices. Patient safety is paramount, but so is the ability to adapt procurement, waste management, and compliance systems to evolving laws.
Our team supports healthcare providers and manufacturers with ISO 13485 quality systems, MDR/IVDR consultancy, and risk management frameworks that ensure compliance without compromising sustainability goals. With expertise in AI governance, advanced materials, and 3D printing technologies, we help organizations navigate complex regulatory landscapes while building safer, smarter, and globally compliant medical devices.
Partner with TS Quality & Engineering to turn regulatory challenges into opportunities for innovation, trust, and resilience.




















